35 percent lower risk for diabetes, 20 percent reduced risk for hypertension seen for sugar restriction in first three years after conception
THURSDAY, Nov. 7, 2024 (HealthDay News) — Sugar restriction during the first 1,000 days after conception lowers a child”s risk for later developing type 2 diabetes and hypertension, according to a study published online Oct. 31 in Science.
Tadeja Gracner, Ph.D., from the University of Southern California in Los Angeles, and colleagues examined the impact of sugar exposure within 1,000 days since conception on diabetes and hypertension. The analysis used a quasi-experimental design based on data from adults conceived just before and after the end of the United Kingdom sugar rationing in September 1953, which restricted sugar intake to levels within current dietary guidelines. Consumption nearly doubled immediately after rationing ended.
The researchers found that early-life rationing reduced diabetes and hypertension risk by about 35 and 20 percent, respectively. Similarly, rationing delayed disease onset by four and two years, respectively. With in-utero exposure restriction, protection was seen and increased with postnatal sugar restriction, especially after six months when solid foods likely began. One-third of the risk reduction was accounted for by in-utero sugar rationing.
“Parents need information about what works, and this study provides some of the first causal evidence that reducing added sugar early in life is a powerful step towards improving children”s health over their lifetimes,” coauthor Claire Boone, from McGill University in Montreal and the University of Chicago, said in a statement.
Abstract/Full Text (subscription or payment may be required)
Pregnancy Complications Linked to Subsequent Risk for Cardiometabolic-Renal Conditions
Isometric Exercise Training Three Times a Week Preserves Cardiovascular Benefits
Sugar Exposure in Early Life Linked to Anxiety in Adulthood
IBD Not Linked to Risk for Hypertensive Disorders of Pregnancy Overall
Low Levels of Placental Growth Factor in Pregnancy Linked to Subsequent ADHD in Offspring
Recommendations Issued for Use of Incretin-Based Meds in Pregnancy
Serum 25(OH)D May Serve as Biomarker of Disease Activity in IBD
Maternal Vitamin D Status Linked to Preterm Delivery